Related Experiment Video
Updated: Jul 20, 2025

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.6K
Engineering Platelet Membrane Imitating Nanoparticles for Targeted Therapeutic Delivery
Shradha B Adhalrao1, Kisan R Jadhav1, Prashant L Patil1
1Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Sector 8 CBD Belapur, Navi Mumbai - 400614, Maharashtra, India.
Current Pharmaceutical Biotechnology
|August 4, 2023
Summary
Platelet Membrane Imitating Nanoparticles (PMINs) offer a novel drug delivery system by mimicking platelet membranes for targeted therapy. These nanoparticles enhance drug efficacy and reduce side effects in conditions like cancer and atherosclerosis.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Platelets play crucial roles in physiological processes and pathological conditions like cancer and atherosclerosis.
- Platelet Membrane Imitating Nanoparticles (PMINs) leverage platelet membrane structure and function for advanced drug delivery.
- Current drug delivery systems face challenges in targeting specificity and reducing off-target effects.
Purpose of the Study:
- To prepare and characterize platelet membrane-like nanoparticles (PMINs).
- To explore the advancements of PMINs in targeted therapy for various diseases.
- To evaluate the potential of PMINs as a next-generation drug delivery platform.
Main Methods:
- Engineering PMINs involves separating and purifying platelet membranes.
- Therapeutic cargo is integrated into the platelet membrane.
- The modified membrane is encapsulated within a nanoparticle scaffold.
Main Results:
- PMINs exhibit high specificity in binding to target cells, reducing off-target effects.
- The system successfully incorporates therapeutic agents for targeted delivery.
- Characterization confirms the successful preparation of PMINs with potential therapeutic applications.
Conclusions:
- PMINs represent a promising drug delivery system combining platelet membrane advantages with nanoparticle technology.
- The ability to customize PMINs with specific cargo and surface markers opens new avenues for targeted medicine.
- Further research and clinical trials are necessary to optimize PMINs for widespread therapeutic use.

